Tulieve (tulathromycin injection) Introduction at 2023 NCBA Convention
Cattle producers, veterinarians and industry representatives attending the 2023 NCBA Convention in New Orleans can learn more about new Tulieve (tulathromycin injection), the newest anti-infective product from Norbrook.
Eric Moore, DVM, director of technical services for Norbrook, says a major advantage of Tulieve over other tulathromycin injectables is its availability in four different size plastic bottles, from 100 mL to 1 liter. Two of these are plastic hanger bottles, he says, making it easier to handle while reducing risk of product loss.
“This rapidly absorbed, long-acting, single-shot antibiotic has proven highly effective in treating a broad range of bacterial pathogens that affect cattle,” Moore notes. “We are excited to offer this alternative to Draxxin (tulathromycin injection) Injectable Solution in our exclusive plastic packaging as part of the Norbrook portfolio of anti-infective solutions for producers and their veterinarians.”
Moore says the addition of Tulieve establishes Norbrook as the animal health manufacturer with the most complete antibiotic portfolio, now providing five classes of antibiotics.
The annual NCBA Convention and Trade Show are February 1-3, 2023, in New Orleans. Moore and company technical representatives will be at the Norbrook exhibit to provide more information about new Tulieve as well as their full line of cattle health products, including Noromycin 300 LA (oxytetracycline injection), Norfenicol (florfenicol) Injection and Cefenil RTU (ceftiofur hydrochloride) Injection. In addition, company representatives can help prepare producers and veterinarians for the new FDA antibiotic-use guidelines that go into effect this coming June.
For more information about new Tulieve (tulathromycin injection) from Norbrook and its portfolio of cattle products, visit Norbrook.com. To schedule a time to visit with Dr. Moore during the NCBA Convention and Trade Show, contact Jill Means at 515-710-2667 or email at Jill.Means@modop.com.
